[S-6059 preparation].
D000818:Animals; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000378:metabolism; D002511:Cephalosporins / Q000378:metabolism; D002513:Cephamycins / Q000009:adverse effects / Q000378:metabolism; D055598:Chemical Phenomena; D002626:Chemistry, Pharmaceutical; D002627:Chemistry, Physical; D004355:Drug Stability; D006801:Humans; D051379:Mice; D009070:Moxalactam; D051381:Rats
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D002513:Cephamycins; D009070:Moxalactam